Synthesizing Angiotensin Receptor Aggregates via Stable Salt Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide and its analogues is hindered by extreme sensitivity to light and water, leading to unstable solid-state formulations and difficulties in industrial-scale production due to the formation of undesired by-products and insolubility issues.
Innovation Solution
A process involving the reaction of a compound with a suitable leaving group and a base to form a stable salt compound, conducted in the presence of solvents and under controlled temperature and pressure conditions, allowing for the formation of a stable pharmaceutically-acceptable salt without isolating the free compound, and optimizing Suzuki coupling reactions to address insolubility problems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the compound is synthesized and stored as a solid-state formulation, then it provides convenient pharmaceutical dosage form, but it becomes chemically unstable due to sensitivity to light and water
Solution Approach 1:
The patent applies inert atmosphere by conducting the synthesis reaction under nitrogen or argon atmosphere to exclude oxygen and moisture. This prevents oxidative degradation and hydrolysis of the sensitive compound during synthesis, maintaining chemical stability while enabling pharmaceutical formulation development.
Solution Approach 2:
The patent extracts the compound from unstable solid-state formulations and stabilizes it by converting to salt forms (such as hydrochloride salts) that exhibit improved chemical stability. This extraction of the unstable free base form and replacement with stable salt forms resolves the contradiction between solid-state convenience and chemical stability.
2Productivity
If Suzuki coupling reaction is conducted at elevated temperatures to improve reaction rate, then productivity increases, but undesired by-products form and purity decreases
Solution Approach 1:
The patent changes the temperature parameter from elevated temperatures to room temperature or lower for the Suzuki coupling reaction. This parameter change slows the reaction rate but prevents side reactions and by-product formation, maintaining high purity while still achieving acceptable productivity through optimized reaction time and catalyst selection.
Solution Approach 2:
The patent introduces a specific palladium catalyst as an intermediary to mediate the Suzuki coupling reaction at lower temperatures. This catalyst enables the reaction to proceed efficiently at room temperature without requiring elevated temperatures, thus maintaining both productivity and purity by facilitating the reaction under milder conditions.
3Productivity
If strong bases are used in the reaction media to promote the reaction, then reaction efficiency improves, but by-product formation increases and purity becomes unacceptable
Solution Approach 1:
The patent changes the base strength parameter from strong bases to weak bases such as potassium carbonate or sodium bicarbonate. This parameter change maintains sufficient reaction efficiency for the Suzuki coupling while avoiding the formation of undesired by-products that occur with strong bases, thus achieving both acceptable productivity and high purity.
4Productivity
If the synthesis is conducted at industrial scale to meet commercial demand, then productivity increases, but insolubility issues and by-product formation worsen
Solution Approach 1:
The patent applies inert atmosphere at industrial scale by implementing nitrogen or argon blanketing throughout the synthesis process. This prevents oxidation and moisture-related side reactions that become more problematic at larger scales, maintaining purity and process feasibility while achieving commercial production volumes.
Solution Approach 2:
The patent changes the temperature parameter to room temperature or lower for industrial-scale synthesis. This prevents thermal degradation and by-product formation that occur at elevated temperatures, especially important at industrial scale where heat dissipation is more difficult. The milder conditions maintain solubility and process feasibility while achieving required productivity through optimized reaction time.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process results in a stable and pure pharmaceutically-acceptable salt form, suitable for industrial-scale production, overcoming issues of instability and by-product formation, and achieving high yield and purity.
Implementation Method 1
reaction of the resultant compound of formula IV with a suitable base to provide W (i.e. the counter-ion W+), as defined above
Implementation Method 2
A process for the synthesis of C21 is described in Wan et al., J. Med. Chem. 2004, 47, p.5995-6008. The multi-step process described therein starts with Suzuki coupling of N-tert-butylsulfonamide with 1-bromo-4-bromomethylbenzene
Data Source
AI summary
There is provided a new process for the synthesis of compounds of formula I, which are useful as angiotensin (Ang II) type 2 receptor agonists: by reacting a compound of formula II, with an excess of a compound of formula III, wherein W, Z and X have meanings given in the description; followed by reaction of the intermediate so formed with a suitable source of the counter-ion, W.